Which Ductal Carcinoma In Situ Patients May Be Candidates For Less Invasive Therapy
Monday, September 28, 2009 - 20:14
in Health & Medicine
Ductal carcinoma in situ (DCIS), the most common non-invasive lesion of the breast, presents unique challenges for patients and providers largely because the natural course of the untreated disease is not well understood. Because most women diagnosed with DCIS are treated, it is difficult to determine the comparative benefits of different treatment strategies versus active surveillance. An independent panel convened by the NIH urged researchers to identify appropriate biomarkers and other prognostic factors to better predict the risk of developing breast cancer.